• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

澳大利亚一个热带城市中痛风合并症的患病率及痛风管理情况

Prevalence of comorbidities and management of gout in a tropical city in Australia.

作者信息

Jeyaruban Andrew, Soden Muriel, Larkins Sarah

机构信息

College of Medicine, Dentistry James Cook University, Townsville, Australia.

Royal Brisbane and Women's Hospital, Herston, Australia.

出版信息

Rheumatol Int. 2016 Dec;36(12):1753-1758. doi: 10.1007/s00296-016-3580-6. Epub 2016 Oct 21.

DOI:10.1007/s00296-016-3580-6
PMID:27770227
Abstract

To examine the management of gout in general practice in Townsville, Australia, and to explore comorbid conditions in patients with gout. Study will also explore how closely guidelines are being followed in managing gout. Retrospective chart review was conducted from May to November 2014 in three general practices in Townsville. Registers for patients were established by searching "gout" and "gouty arthritis". Three hundred and twenty-one patients were included in the study after excluding inactive patients, patients below age of 18 and patients with cancer. Main outcome measures were prevalence of comorbidities in gout patients, gout medications and adequate serum urate control (≤0.36 mmol/l). Multivariate logistic regression was used to study the relationship between serum urate level, comorbid conditions and lifestyle factors. Hypertension was the most common comorbid condition with 60.8 % of patients followed by obesity and dyslipidaemia. In terms of medication, 46.7 % of patients were on allopurinol, 12.8 % on indomethacin and 13.4 % on diuretics. Eighty-six percentage of patients had serum urate level (sUA) recorded in the previous year. Of these, 32.2 % had a serum urate level below or equal to 0.36 mmol/l. Moreover, 17.4 % of patients had lifestyle advice documented in chart. Male gender was the most influential factor in having poor uric acid control (p < 0.01), followed by not being on allopurinol (p < 0.01) and patients older than 50 years (p = 0.02). Management of gout in this study sample was not entirely concordant with guidelines. The study also suggests a need for possible tighter monitoring and allopurinol dosing regime in older, male patients.

摘要

为研究澳大利亚汤斯维尔地区全科医疗中痛风的管理情况,并探究痛风患者的合并症。本研究还将探讨在痛风管理中遵循指南的程度。2014年5月至11月,在汤斯维尔的三家全科诊所进行了回顾性病历审查。通过搜索“痛风”和“痛风性关节炎”建立患者登记册。排除不活跃患者、18岁以下患者和癌症患者后,321名患者纳入研究。主要观察指标为痛风患者合并症的患病率、痛风药物使用情况以及血清尿酸的充分控制(≤0.36 mmol/L)。采用多因素逻辑回归研究血清尿酸水平、合并症与生活方式因素之间的关系。高血压是最常见的合并症,60.8%的患者患有高血压,其次是肥胖和血脂异常。在药物治疗方面,46.7%的患者使用别嘌醇,12.8%的患者使用吲哚美辛,13.4%的患者使用利尿剂。86%的患者上一年记录了血清尿酸水平(sUA)。其中,32.2%的患者血清尿酸水平低于或等于0.36 mmol/L。此外,17.4%的患者病历中有生活方式建议记录。男性是尿酸控制不佳的最有影响因素(p < 0.01),其次是未使用别嘌醇(p < 0.01)和年龄大于50岁的患者(p = 0.02)。本研究样本中痛风的管理与指南并不完全一致。该研究还表明,可能需要对老年男性患者进行更严格的监测和调整别嘌醇给药方案。

相似文献

1
Prevalence of comorbidities and management of gout in a tropical city in Australia.澳大利亚一个热带城市中痛风合并症的患病率及痛风管理情况
Rheumatol Int. 2016 Dec;36(12):1753-1758. doi: 10.1007/s00296-016-3580-6. Epub 2016 Oct 21.
2
An Observational Study of Gout Prevalence and Quality of Care in a National Australian General Practice Population.澳大利亚全国全科医疗人群中痛风患病率及医疗质量的观察性研究。
J Rheumatol. 2015 Sep;42(9):1702-7. doi: 10.3899/jrheum.150310. Epub 2015 Aug 1.
3
Women with gout: efficacy and safety of urate-lowering with febuxostat and allopurinol.女性痛风患者:别嘌醇和非布司他降低尿酸的疗效和安全性。
Arthritis Care Res (Hoboken). 2012 Feb;64(2):256-61. doi: 10.1002/acr.20680.
4
Achieving serum urate goal: a comparative effectiveness study between allopurinol and febuxostat.实现血清尿酸目标:别嘌醇与非布司他的对比疗效研究。
Postgrad Med. 2014 Mar;126(2):65-75. doi: 10.3810/pgm.2014.03.2741.
5
Gout prevalence and predictors of urate-lowering therapy use: results from a population-based study.痛风患病率及降尿酸治疗使用率的预测因素:一项基于人群的研究结果。
Arthritis Res Ther. 2018 Jul 11;20(1):143. doi: 10.1186/s13075-018-1633-9.
6
Prevalence and associations of gout and hyperuricaemia: results from an Australian population-based study.痛风和高尿酸血症的患病率及相关性:一项基于澳大利亚人群研究的结果。
Intern Med J. 2016 May;46(5):566-73. doi: 10.1111/imj.13006.
7
A world of hurt: failure to achieve treatment goals in patients with gout requires a paradigm shift.一个痛苦的世界:痛风患者未能实现治疗目标需要一种范式转变。
Postgrad Med. 2016 Jan;128(1):34-40. doi: 10.1080/00325481.2016.1113840. Epub 2015 Nov 17.
8
Comorbidity in gout at the time of first diagnosis: sex differences that may have implications for dosing of urate lowering therapy.首次诊断时痛风的合并症:可能对尿酸降低治疗剂量有影响的性别差异。
Arthritis Res Ther. 2018 Jun 1;20(1):108. doi: 10.1186/s13075-018-1596-x.
9
Dyslipidemia, Alcohol Consumption, and Obesity as Main Factors Associated With Poor Control of Urate Levels in Patients Receiving Urate-Lowering Therapy.血脂异常、饮酒和肥胖是与接受降尿酸治疗的患者尿酸水平控制不佳相关的主要因素。
Arthritis Care Res (Hoboken). 2018 Jun;70(6):918-924. doi: 10.1002/acr.23347. Epub 2018 Mar 23.
10
Comparison of topiroxostat and allopurinol in Japanese hyperuricemic patients with or without gout: a phase 3, multicentre, randomized, double-blind, double-dummy, active-controlled, parallel-group study.托匹司他与别嘌醇在日本痛风或非痛风高尿酸血症患者中的比较:一项3期、多中心、随机、双盲、双模拟、活性药物对照、平行组研究。
J Clin Pharm Ther. 2016 Jun;41(3):290-7. doi: 10.1111/jcpt.12391. Epub 2016 Apr 24.

引用本文的文献

1
Prevalence of Hypertension in Sudanese Patients With Gouty Arthritis.苏丹痛风性关节炎患者的高血压患病率
Cureus. 2022 Apr 18;14(4):e24248. doi: 10.7759/cureus.24248. eCollection 2022 Apr.
2
What factors contribute to uncontrolled gout and hospital admission? A qualitative study of inpatients and their primary care practitioners.哪些因素导致痛风失控和住院?一项对住院患者及其初级保健医生的定性研究。
BMJ Open. 2019 Dec 23;9(12):e033726. doi: 10.1136/bmjopen-2019-033726.
3
Gout prevalence and predictors of urate-lowering therapy use: results from a population-based study.

本文引用的文献

1
General practitioners' perspectives on the management of gout: a qualitative study.全科医生对痛风管理的观点:一项定性研究。
Postgrad Med J. 2016 Oct;92(1092):603-7. doi: 10.1136/postgradmedj-2015-133920. Epub 2016 Mar 31.
2
Management of gout in general practice--a systematic review.全科医疗中痛风的管理——一项系统评价
Clin Rheumatol. 2015 Jan;34(1):9-16. doi: 10.1007/s10067-014-2783-z. Epub 2014 Sep 17.
3
Improvement in the management of gout is vital and overdue: an audit from a UK primary care medical practice.
痛风患病率及降尿酸治疗使用率的预测因素:一项基于人群的研究结果。
Arthritis Res Ther. 2018 Jul 11;20(1):143. doi: 10.1186/s13075-018-1633-9.
改善痛风管理至关重要且刻不容缓:来自英国初级保健医疗实践的审计。
BMC Fam Pract. 2013 Nov 14;14:170. doi: 10.1186/1471-2296-14-170.
4
Systematic review of the prevalence of gout and hyperuricaemia in Australia.澳大利亚痛风和高尿酸血症患病率的系统评价
Intern Med J. 2012 Sep;42(9):997-1007. doi: 10.1111/j.1445-5994.2012.02794.x. Epub 2012 Apr 4.
5
Update on gout: new therapeutic strategies and options.痛风最新治疗策略与选择。
Nat Rev Rheumatol. 2010 Jan;6(1):30-8. doi: 10.1038/nrrheum.2009.236.
6
Prescription and comorbidity screening following consultation for acute gout in primary care.初级保健中急性痛风就诊后的处方和合并症筛查。
Rheumatology (Oxford). 2010 Jan;49(1):105-11. doi: 10.1093/rheumatology/kep332. Epub 2009 Nov 17.
7
A survey of the management of gout in primary care.基层医疗中痛风管理的一项调查。
Ir Med J. 2008 May;101(5):147-9.
8
Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000-2005.英国和德国的痛风:2000 - 2005年全科医疗中的患病率、合并症及管理
Ann Rheum Dis. 2008 Jul;67(7):960-6. doi: 10.1136/ard.2007.076232. Epub 2007 Nov 2.
9
Quality of care for gout in the US needs improvement.美国痛风的护理质量有待提高。
Arthritis Rheum. 2007 Jun 15;57(5):822-9. doi: 10.1002/art.22767.
10
Concordance of the management of chronic gout in a UK primary-care population with the EULAR gout recommendations.英国基层医疗人群中慢性痛风管理与欧洲抗风湿病联盟痛风建议的一致性。
Ann Rheum Dis. 2007 Oct;66(10):1311-5. doi: 10.1136/ard.2007.070755. Epub 2007 May 15.